http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102786497-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3d7e466c44c7b54e2a48e4bf62665ef
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-033
filingDate 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_308e482b85192541ae22736b04db8cae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6662ef9c2b30b96b6e26d6e6341194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c0af15eec819fd51e70b5779ce2d20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f926c560f9685a7683c3653791cdd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be09291d3d3dfe239f3542954d7c8243
publicationDate 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102786497-A
titleOfInvention Preparation method of piperazine compounds and intermediates thereof
abstract The invention discloses a preparation method of piperazine compounds and intermediates thereof, belonging to the field of drug synthesis. The compounds and their intermediates can be used to prepare drugs for diseases of the central nervous system, such as analgesics, drugs for drug addiction, drugs for schizophrenia, drugs for Parkinson's disease and the like. The preparation method of the compound and its intermediate represented by the following structural formula of the present invention has the advantages of high reaction yield, short reaction time, easy to obtain and relatively cheap raw materials, convenient separation and purification of products, easy control of the reaction, and less generation of three wastes. The advantages of low risk. Because the piperazine compounds are widely used, the present invention has certain practical production significance; .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111417637-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980229-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3722299-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980229-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021505594-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685399-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111417637-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111944539-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791108-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103224476-A
priorityDate 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127025258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467691460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465191691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467532809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467331923

Total number of triples: 34.